MedPath

OPHIREX, INC.

OPHIREX, INC. logo
🇺🇸United States
Ownership
Holding
Established
2015-01-01
Employees
11
Market Cap
-
Website
http://www.ophirex.com

Clinical Trials

5

Active:0
Completed:3

Trial Phases

1 Phases

Phase 2:5

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Phase 2
5 (100.0%)

Broad-spectrum Rapid Antidote: Varespladib IV to Oral Trial for Snakebite (BRAVIO)

Phase 2
Completed
Conditions
Snakebite
Envenoming, Snake
Interventions
Drug: Placebo intravenous form
Drug: Placebo - oral form
Drug: varespladib-methyl- oral form
First Posted Date
2023-02-08
Last Posted Date
2025-06-27
Lead Sponsor
Ophirex, Inc.
Target Recruit Count
140
Registration Number
NCT05717062
Locations
🇺🇸

UF Health Shands Hospital, Gainesville, Florida, United States

🇺🇸

Banner University Medical Center - Phoenix, Phoenix, Arizona, United States

🇺🇸

Arizona Poison & Drug Information Center, Tucson, Arizona, United States

and more 7 locations

Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite

Phase 2
Completed
Conditions
Snakebites
Envenoming, Snake
Envenoming
Envenomation, Snake
Interventions
Drug: Placebo
Drug: Standard of care (SOC)
First Posted Date
2021-08-09
Last Posted Date
2025-07-01
Lead Sponsor
Ophirex, Inc.
Target Recruit Count
95
Registration Number
NCT04996264
Locations
🇺🇸

University of Arizona, Tucson, Arizona, United States

🇺🇸

Loma Linda University Medical Center, Loma Linda, California, United States

🇺🇸

University of Florida Health, Jacksonville, Florida, United States

and more 13 locations

Study of Varespladib in Patients Hospitalized With Severe COVID-19

Phase 2
Terminated
Conditions
Coronavirus Disease 2019
Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2
Interventions
Drug: Placebo
First Posted Date
2021-07-21
Last Posted Date
2025-05-15
Lead Sponsor
Ophirex, Inc.
Target Recruit Count
18
Registration Number
NCT04969991
Locations
🇺🇸

Ventura Clinical Trials, Ventura, California, United States

🇺🇸

University of Miami Miller School of Medicine, Miami, Florida, United States

🇺🇸

Westchester Research Center at Westchester General Hospital, Miami, Florida, United States

and more 4 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.